TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Mar 2025

Income Metrics

Revenue 7.3M
Gross Profit 2.7M 37.14%
Operating Income -683.0K -9.33%
Net Income -671.0K -9.16%
EPS (Diluted) $-0.10

Balance Sheet Metrics

Total Assets 17.5M
Total Liabilities 4.1M
Shareholders Equity 13.4M
Debt to Equity 0.30

Cash Flow Metrics

Free Cash Flow -654.0K

Revenue & Profitability Trend

SunLink Health Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i32.4M34.3M41.3M40.7M47.8M
Cost of Goods Sold i19.5M19.8M21.2M19.1M23.2M
Gross Profit i12.9M14.5M20.1M21.6M24.7M
Gross Margin % i39.8%42.2%48.6%53.1%51.6%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i10.9M10.5M19.6M14.4M20.2M
Other Operating Expenses i3.0M2.6M4.3M4.0M3.4M
Total Operating Expenses i13.9M13.1M23.9M18.4M23.5M
Operating Income i-2.4M74.0K-5.3M1.9M-329.0K
Operating Margin % i-7.4%0.2%-12.9%4.6%-0.7%
Non-Operating Items
Interest Income i-----
Interest Expense i----29.0K
Other Non-Operating Income2.0K30.0K3.7M5.2M68.0K
Pre-tax Income i-2.3M191.0K-1.6M7.0M-290.0K
Income Tax i-5.0K-7.0K107.0K63.0K296.0K
Effective Tax Rate % i0.0%-3.7%0.0%0.9%0.0%
Net Income i-1.5M-1.8M-2.0M6.9M-1.1M
Net Margin % i-4.7%-5.2%-4.9%16.9%-2.4%
Key Metrics
EBITDA i-455.0K2.1M-6.8M3.0M1.1M
EPS (Basic) i$-0.22$-0.26$-0.29$1.00$-0.16
EPS (Diluted) i$-0.22$-0.26$-0.29$0.99$-0.16
Basic Shares Outstanding i70380007019000694500069070006957000
Diluted Shares Outstanding i70380007019000694500069070006957000

Income Statement Trend

SunLink Health Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i7.2M4.5M6.8M10.0M11.2M
Short-term Investments i-----
Accounts Receivable i3.4M2.6M4.6M4.2M4.3M
Inventory i1.6M1.6M1.7M1.9M1.9M
Other Current Assets1.6M1.6M1.9M2.3M2.6M
Total Current Assets i15.7M12.3M16.8M21.9M19.9M
Non-Current Assets
Property, Plant & Equipment i516.0K798.0K17.1M15.2M14.8M
Goodwill i1.2M1.2M1.2M1.2M1.3M
Intangible Assets i1.2M1.2M1.2M1.2M1.3M
Long-term Investments-----
Other Non-Current Assets443.0K6.3M523.0K591.0K500.0K
Total Non-Current Assets i4.9M11.0M11.1M9.6M8.0M
Total Assets i20.6M23.3M27.9M31.6M28.0M
Liabilities
Current Liabilities
Accounts Payable i1.9M1.1M1.3M1.1M872.0K
Short-term Debt i331.0K334.0K392.0K3.4M1.8M
Current Portion of Long-term Debt-----
Other Current Liabilities-1.3M--4.5M
Total Current Liabilities i4.2M4.9M7.7M9.7M11.4M
Non-Current Liabilities
Long-term Debt i197.0K481.0K871.0K927.0K2.6M
Deferred Tax Liabilities i-69.0K69.0K0-
Other Non-Current Liabilities229.0K309.0K192.0K162.0K248.0K
Total Non-Current Liabilities i426.0K982.0K1.1M1.1M2.8M
Total Liabilities i4.6M5.9M8.8M10.8M14.2M
Equity
Common Stock i3.5M3.5M3.5M3.5M3.4M
Retained Earnings i1.5M3.0M4.8M6.8M-81.0K
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i16.0M17.4M19.1M20.8M13.7M
Key Metrics
Total Debt i528.0K815.0K1.3M4.3M4.3M
Working Capital i11.5M7.4M9.1M12.3M8.5M

Balance Sheet Composition

SunLink Health Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i-1.5M-1.8M-2.0M6.9M-1.1M
Depreciation & Amortization i2.0M2.1M1.5M1.4M1.4M
Stock-Based Compensation i---028.0K
Working Capital Changes i-1.6M-126.0K1.2M-7.2M3.2M
Operating Cash Flow i-1.2M129.0K850.0K811.0K3.6M
Investing Activities
Capital Expenditures i5.0K30.0K11.0K43.0K559.0K
Acquisitions i6.7M0--0
Investment Purchases i-----
Investment Sales i-----
Investing Cash Flow i6.7M30.0K62.0K43.0K559.0K
Financing Activities
Share Repurchases i---0-102.0K
Dividends Paid i-----
Debt Issuance i---03.2M
Debt Repayment i-14.0K-40.0K-36.0K-35.0K-3.0M
Financing Cash Flow i-14.0K-40.0K-36.0K-35.0K99.0K
Free Cash Flow i-4.4M-1.9M-3.2M-1.2M2.8M
Net Change in Cash i5.6M119.0K876.0K819.0K4.2M

Cash Flow Trend

SunLink Health Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) -5.07
Price to Book 0.59
Price to Sales 0.25
PEG Ratio 0.10

Profitability Ratios

Profit Margin 5.55%
Operating Margin -9.33%
Return on Equity -22.34%
Return on Assets -13.62%

Financial Health

Current Ratio 3.92
Debt to Equity 4.98
Beta 1.15

Per Share Data

EPS (TTM) $-0.39
Book Value per Share $1.91
Revenue per Share $4.42

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
ssy7.0M-5.070.59-22.34%5.55%4.98
Walgreens Boots 10.4B27.101.44-69.58%-4.07%409.88
Wellgistics Health 65.6M-4.6848.46-101.81%-123.31%2,722.18
PetMed Express 58.5M262.000.560.36%0.15%1.15
Scienture Holdings 18.3M1.700.18-54.26%4.39%5.30
Hong Kong Pharma 14.3M6.262.71-0.59%-0.13%47.60

Financial data is updated regularly. All figures are in the company's reporting currency.